BlackRock Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $406K | Buy |
8,291
+386
| +5% | +$18.9K | ﹤0.01% | 2263 |
|
|
2016
Q3 | $378K | Sell |
7,905
-15,787
| -67% | -$755K | ﹤0.01% | 2262 |
|
|
2016
Q2 | $1.27M | Buy |
23,692
+355
| +2% | +$19K | ﹤0.01% | 1625 |
|
|
2016
Q1 | $1.04M | Sell |
23,337
-2,198
| -9% | -$98.3K | ﹤0.01% | 1680 |
|
|
2015
Q4 | $974K | Sell |
25,535
-18,290
| -42% | -$698K | ﹤0.01% | 1697 |
|
|
2015
Q3 | $1.4M | Sell |
43,825
-124,356
| -74% | -$3.96M | ﹤0.01% | 1486 |
|
|
2015
Q2 | $5.56M | Sell |
168,181
-4,485
| -3% | -$148K | 0.01% | 941 |
|
|
2015
Q1 | $7.11M | Buy |
172,666
+1,385
| +0.8% | +$57K | 0.01% | 867 |
|
|
2014
Q4 | $6.98M | Buy |
171,281
+1,840
| +1% | +$75K | 0.01% | 865 |
|
|
2014
Q3 | $6.21M | Buy |
169,441
+69,993
| +70% | +$2.57M | 0.01% | 902 |
|
|
2014
Q2 | $4.61M | Buy |
99,448
+87,025
| +701% | +$4.03M | ﹤0.01% | 972 |
|
|
2014
Q1 | $511K | Sell |
12,423
-6,222
| -33% | -$256K | ﹤0.01% | 2006 |
|
|
2013
Q4 | $711K | Sell |
18,645
-100,800
| -84% | -$3.84M | ﹤0.01% | 1730 |
|
|
2013
Q3 | $2.85M | Buy |
119,445
+111,888
| +1,481% | +$2.67M | ﹤0.01% | 1079 |
|
|
2013
Q2 | $128K | Buy |
+7,557
| New | +$128K | ﹤0.01% | 2730 |
|